These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25855138)

  • 1. Dasatinib-induced gastric antral vascular ectasia in a patient with acute lymphoblastic leukaemia.
    Ohta S; Najima Y; Imamura J
    Br J Haematol; 2015 Jun; 169(5):612. PubMed ID: 25855138
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of dasatinib in the patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia with resistance to imatinib and renal failure.
    Sonmez M; Cobanoglu U; Ovali E; Omay SB
    J Clin Pharm Ther; 2008 Jun; 33(3):329-30. PubMed ID: 18452422
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid-onset pulmonary arterial hypertension in a patient with acute lymphoblastic leukemia treated with dasatinib.
    Kim JC; Shin SH; Yi HG; Kim SH; Woo SI; Kim DH; Park KS; Kwan J
    Herz; 2013 Dec; 38(8):931-3. PubMed ID: 23430094
    [No Abstract]   [Full Text] [Related]  

  • 4. Dasatinib: for some difficult cases of adult leukaemia.
    Prescrire Int; 2008 Aug; 17(96):149-50. PubMed ID: 19496239
    [No Abstract]   [Full Text] [Related]  

  • 5. Pneumocystis jiroveci pneumonia in patients receiving dasatinib treatment.
    Chang H; Hung YS; Chou WC
    Int J Infect Dis; 2014 Aug; 25():165-7. PubMed ID: 24932855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dasatinib-induced pulmonary hypertension in acute lymphoblastic leukemia: case report.
    Taçoy G; Çengel A; Özkurt ZN; Türkoğlu S
    Turk Kardiyol Dern Ars; 2015 Jan; 43(1):78-81. PubMed ID: 25655855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dasatinib (Sprycel) for CML and Ph + ALL.
    Med Lett Drugs Ther; 2007 Jan; 49(1252):6-7. PubMed ID: 17220814
    [No Abstract]   [Full Text] [Related]  

  • 8. Hair depigmentation and vitiligo-like lesions in a leukaemic paediatric patient during chemotherapy with dasatinib.
    Brazzelli V; Grasso V; Barbaccia V; Manna G; Rivetti N; Zecca M; Giorgiani G; Vassallo C; Borroni G
    Acta Derm Venereol; 2012 Mar; 92(2):218-9. PubMed ID: 22307953
    [No Abstract]   [Full Text] [Related]  

  • 9. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sprycel for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylate.
    Brave M; Goodman V; Kaminskas E; Farrell A; Timmer W; Pope S; Harapanhalli R; Saber H; Morse D; Bullock J; Men A; Noory C; Ramchandani R; Kenna L; Booth B; Gobburu J; Jiang X; Sridhara R; Justice R; Pazdur R
    Clin Cancer Res; 2008 Jan; 14(2):352-9. PubMed ID: 18223208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral subdural hemorrhage as a serious adverse event of dasatinib in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Yhim HY; Kim HS; Lee NR; Song EK; Kwak JY; Yim CY
    Int J Hematol; 2012 May; 95(5):585-7. PubMed ID: 22403059
    [No Abstract]   [Full Text] [Related]  

  • 12. New drugs: paliperidone, dasatinib, and decitabine.
    Hussar DA
    J Am Pharm Assoc (2003); 2007; 47(2):298-302. PubMed ID: 17510013
    [No Abstract]   [Full Text] [Related]  

  • 13. Panniculitis during dasatinib therapy for imatinib-resistant chronic myelogenous leukemia.
    Assouline S; Laneuville P; Gambacorti-Passerini C
    N Engl J Med; 2006 Jun; 354(24):2623-4. PubMed ID: 16775249
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful pregnancy involving a man with chronic myeloid leukemia on dasatinib.
    Oweini H; Otrock ZK; Mahfouz RA; Bazarbachi A
    Arch Gynecol Obstet; 2011 Jan; 283(1):133-4. PubMed ID: 20473616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance therapy with dasatinib after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Teng CL; Yu JT; Chen HC; Hwang WL
    Ann Hematol; 2013 Aug; 92(8):1137-9. PubMed ID: 23307602
    [No Abstract]   [Full Text] [Related]  

  • 16. Dasatinib 140 mg once daily versus 70 mg twice daily in patients with Ph-positive acute lymphoblastic leukemia who failed imatinib: Results from a phase 3 study.
    Lilly MB; Ottmann OG; Shah NP; Larson RA; Reiffers JJ; Ehninger G; Müller MC; Charbonnier A; Bullorsky E; Dombret H; Brigid Bradley-Garelik M; Zhu C; Martinelli G
    Am J Hematol; 2010 Mar; 85(3):164-70. PubMed ID: 20131302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dasatinib-related pneumonia? An example of pharmacovigilance survey].
    Audemard A; de la Gastine B; Chantepie S; Verger H; Gac AC; Bergot E; Reman O
    Rev Mal Respir; 2015 Jan; 32(1):84-6. PubMed ID: 25618211
    [No Abstract]   [Full Text] [Related]  

  • 18. Dasatinib, a multikinase inhibitor: therapy, safety, and appropriate management of adverse events.
    Shayani S
    Ther Drug Monit; 2010 Dec; 32(6):680-7. PubMed ID: 20864900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible dasatinib-related pulmonary arterial hypertension diagnosed by noninvasive echocardiography.
    Wang HC; Lee CS; Liu TC
    Kaohsiung J Med Sci; 2015 Mar; 31(3):165-6. PubMed ID: 25744241
    [No Abstract]   [Full Text] [Related]  

  • 20. Excellent response to dasatinib of childhood Philadelphia positive intracranial acute lymphoblastic leukaemia tumours.
    Bhadri VA; Satharasinghe K; Sugo E; Barbaric D; Trahair TN
    Br J Haematol; 2011 Feb; 152(3):347-9. PubMed ID: 21155759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.